LA-EP2006

DRUG2 trials

Sponsors

Sandoz

Conditions

Breast CancerBreast NeoplasmsChemotherapeutic ToxicityChemotherapy-induced NeutropeniaNeutropenic Complications

Phase 3

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

CompletedNCT01516736

SandozBreast Cancer, Chemotherapy-induced Neutropenia

Start: 2012-03-31End: 2013-12-31Updated: 2017-08-30

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®

CompletedNCT01735175

SandozBreast Neoplasms, Chemotherapeutic Toxicity, Chemotherapy-induced Neutropenia +1

Start: 2012-06-30End: 2014-02-28Updated: 2017-08-07

Related Papers

Pooled analysis of two randomized, double-blind trials comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer.

2017-09-019 citations